Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda. During the ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of the ...

We recently published a list of 15 Best Defensive Stocks Amid Market Volatility In this article, we are going to take a look ...

Merck will partner with Chinese biotech Abbisko Therapeutics to market and sell the bone-tumor treatment pimicotinib globally, expanding its commercialization rights for the drug beyond Asia. The ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in ... and animal health products. Merck & Co., Inc. (NYSE:MRK) is advancing psychedelic research, particularly for treatment ...

READ ALSO: 10 Best Performing Pharma Stocks So Far in ... and markets a range of vaccines and veterinary pharmaceutical products. Merck & Co., Inc.’s (NYSE:MRK) pipeline lends it a competitive ...

The state-of-the-art manufacturing facility leverages best practices and learnings from across the Merck Manufacturing Division network ... technological advances, new products and patents attained by ...

In a filing with the SEC, Merck (NYSE:MRK) noted that the U.S. Department of Health and Human Services, which oversees programs such as Medicare, selected one of its best-selling drugs ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.